Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression

BACKGROUND: To determine the association between circadian pathway genetic variants and the risk of prostate cancer progression. METHODS: We systematically evaluated 79 germline variants in nine circadian pathway genes in a cohort of 458 patients with localized prostate cancer as the discovery phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Chia-Cheng, Chen, Lih-Chyang, Chiou, Chih-Yung, Chang, Yu-Jia, Lin, Victor C., Huang, Chao-Yuan, Lin, I-Ling, Chang, Ta-Yuan, Lu, Te-Ling, Lee, Cheng-Hsueh, Huang, Shu-Pin, Bao, Bo-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451277/
https://www.ncbi.nlm.nih.gov/pubmed/30996687
http://dx.doi.org/10.1186/s12935-019-0811-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451277/
https://www.ncbi.nlm.nih.gov/pubmed/30996687
http://dx.doi.org/10.1186/s12935-019-0811-4

Ejemplares similares